Zimmer Biomet Holdings, Inc.
Market Cap
16B
Short interest (May 15)
4.7%
Net Short (Jun 03 ): 0.1%
Borrow Fee
0.27%
↑ 0.4%
Available Shares
1M
↓ 8.5%
Price Chart
Company Overview
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.